女人隐私毛多图片欣赏

公司简介
中科利健是一家创新型生物制药企业,专注于靶向组织微环境的创新药研发,公司成立于2018年。
组织架构
中科利健是一家创新型生物制药企业,专注于靶向组织微环境的创新药研发,公司成立于2018年。
核心团队
中科利健是一家创新型生物制药企业,专注于靶向组织微环境的创新药研发,公司成立于2018年。
研发管线A
中科利健是一家创新型生物制药企业,专注于靶向组织微环境的创新药研发,公司成立于2018年。
企业新闻
中科利健是一家创新型生物制药企业,专注于靶向组织微环境的创新药研发,公司成立于2018年。
行业新闻
中科利健是一家创新型生物制药企业,专注于靶向组织微环境的创新药研发,公司成立于2018年。
招纳贤士
中科利健是一家创新型生物制药企业,专注于靶向组织微环境的创新药研发,公司成立于2018年。
联系方式
中科利健是一家创新型生物制药企业,专注于靶向组织微环境的创新药研发,公司成立于2018年。
公司简介
About us
中科利健是一家创新型生物制药企业,专注于靶向组织微环境的创新药研发,公司成立于2018年,注册资本1亿元人民币,坐落于广州莱迪创新科技园。公司由中国科学院广州生物医药与健康研究院与吉富创业投资股份有限公司合资成立,研发团队来自中科院广州生物院,是中国科研机构与资本的有力结合。

中科利健专注于采用独特的靶向组织微环境的方法开发新药,针对的适应症包括癌症、炎症和疼痛,组织微环境在这些疾病的发病过程中起到重要作用。
“Our company is targeting the Tissue Micro-Environment (TiME), a key driving force of human diseases, as a fresh approach for making new medicines”

Legion (Lijien) Pharmaceuticals, is a new biotechnology company established in 2018 and located in the great city of Guangzhou that is strategically located in the Pearl River Delta of Southern China. The Company is the creation of GF Investments, Inc. and the Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, two mainstay institutions in Guangzhou, representing a coordinated merging of expertise in capital investment and drug discovery sciences. With the merging of these two centers of excellence, Legion Pharmaceuticals on day one is poised to be both an early and late stage clinical biotechnology company, focused on developing and commercializing new medicines. Legion (Lijien) Pharmaceuticals differentiates itself from other biotechnology companies by its unique approach in targeting diseases that are mediated primarily by the Tissue Micro-Environment (TiME), which is a key driving force of many human diseases. Our TiME based drug discovery portfolio is unique and focused in three primary areas including Cancer, Inflammation and Pain (CIP), where the tissue microenvironment is known to play an important role in disease pathology.
查看详情
女人隐私毛多图片欣赏 女人隐私毛多图片欣赏 女人隐私毛多图片欣赏